A new webinar series for healthcare professionals will explore how individuals with diabetes and endocrine problems have been impacted by the coronavirus.
The severe and lasting impact of COVID-19 on both conditions will be the focal point of the online event entitled ‘What’s new in endocrinology and diabetes: The effects of COVID-19’.
A panel of diabetes and endocrine experts will discuss whether predating endocrine illnesses contributed to the severity of coronavirus infections.
The three webinars are being hosted by The Royal Society of Medicine in association with The Society for Endocrinology and will take place from Wednesday, September 8 to Friday, September 10. Each virtual event will be held from 4:30pm to 6:05pm.
Attendees will receive a CPD certificate with a singular CPD credit for each webinar.
The first episode will discuss the impact coronavirus has had on diabetes and glucocorticoid replacement. During the opening workshop, experts will examine the role of androgens and underlying diabetes on patients’ susceptibility to COVID-19.
The influence of vitamin D, metabolism and glucocorticoid replacement and the impact of sodium balance on patient susceptibility from COVID-19 will be the focal point during the second webinar.
During the final webinar, experts will provide an update on the influence of COVID on thyroid disease, and will examine the role of oestrogen and underlying thyroid disorders on susceptibility to COVID-19.
Registration for this webinar will close two hours prior to the start time.
To find out more about this webinar series, click here.